X-154411756-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000116.5(TAFAZZIN):c.-88G>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0121 in 893,447 control chromosomes in the GnomAD database, including 80 homozygotes. There are 3,182 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000116.5 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAFAZZIN | NM_000116.5 | c.-88G>C | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 11 | ENST00000601016.6 | NP_000107.1 | ||
TAFAZZIN | NM_000116.5 | c.-88G>C | 5_prime_UTR_variant | Exon 1 of 11 | ENST00000601016.6 | NP_000107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAFAZZIN | ENST00000601016 | c.-88G>C | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 11 | 1 | NM_000116.5 | ENSP00000469981.1 | |||
TAFAZZIN | ENST00000601016 | c.-88G>C | 5_prime_UTR_variant | Exon 1 of 11 | 1 | NM_000116.5 | ENSP00000469981.1 |
Frequencies
GnomAD3 genomes AF: 0.0101 AC: 1133AN: 112454Hom.: 6 Cov.: 24 AF XY: 0.00983 AC XY: 341AN XY: 34684
GnomAD3 exomes AF: 0.00825 AC: 746AN: 90435Hom.: 4 AF XY: 0.00831 AC XY: 275AN XY: 33089
GnomAD4 exome AF: 0.0124 AC: 9650AN: 780948Hom.: 74 Cov.: 13 AF XY: 0.0131 AC XY: 2841AN XY: 216558
GnomAD4 genome AF: 0.0101 AC: 1131AN: 112499Hom.: 6 Cov.: 24 AF XY: 0.00982 AC XY: 341AN XY: 34739
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
3-Methylglutaconic aciduria type 2 Benign:1
- -
Left ventricular noncompaction cardiomyopathy Benign:1
- -
Primary dilated cardiomyopathy Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Endocardial fibroelastosis Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at